Influenza Virus. Influenza A virus. Influenza B virus. Influenza C virus

Similar documents
Outline. Seasonal Influenza & Pneumonia National & State Statistics Novel Influenza A H1N1

Influenza Clinical Bulletin # 3: October 8, 2009 Vaccination Guidelines for Patients for Influenza

2011 Immunization Update for Pharmacists. Kenneth McCall, BSPharm, PharmD Associate Professor & Dept. Chair UNE College of Pharmacy

Kenneth McCall, BSPharm, PharmD Associate Professor UNE President Maine Pharmacy Association

Disclosures. No support One off-label recommendation

Kenneth McCall, BSPharm, PharmD Associate Professor UNE

INFLUENZA 2009 H1N1. INACTIVATED (the flu shot ) W H A T Y O U N E E D T O K N O W. 1 What is 2009 H1N1 influenza? H1N1 influenza vaccine

Influenza Update. Lisa Grohskopf, MD, MPH Influenza Division, CDC. NAICP Call 6 October 2015

Talkin Flu Mid-America Immunization Coalition August 18, William Atkinson, MD, MPH Immunization Action Coalition

Key Facts about Seasonal Flu Vaccine from the Centers for Disease Control and Prevention

Nothing to disclose. Influenza Update. Influenza Biology. Influenza Biology. Influenza A 12/15/2014

CONTAGIOUS COMMENTS Department of Epidemiology

Needle Facts: Immunization Update Mirada Wilhelm, PharmD Clinical Associate Professor SIUE School of Pharmacy

HELP PREVENT THE FLU WITH FLUMIST QUADRIVALENT

Influenza Vaccines: Giving the Right Dose at the Right Time. Agenda

Human Influenza. Dr. Sina Soleimani. Human Viral Vaccine Quality Control 89/2/29. November 2, 2011 HVVQC ١

10/6/2014. INFLUENZA: Why Should We Take The Vaccine? OUTLINE INFLUNZA VIRUS INFLUENZA VIRUS INFLUENZA VIRUS

CAPE MAY COUNTY DEPARTMENT of HEALTH

Influenza. Alan P. Agins, Ph.D Objectives. Influenza Update: Influenza. Disclosures. Influenza Virus.

Influenza A 6/23/2010. Lisa Winston, MD UCSF / San Francisco General Hospital Divisions of Infectious Diseases and Hospital Medicine

Prevention of Influenza: Recommendations for Influenza Immunization of Children,

Immunization with Influenza Vaccine (Inf)

9/11/2018. Influenza and Influenza Vaccines. Influenza. Influenza Virus. Highly infectious viral illness. First pandemic in 1580

Influenza: Virus, vaccines and vaccination strategies

Questions and Answers on Immunization Regulations Pertaining to Children Attending School/ Higher Education

Navigating Options for Influenza Immunization, What a difference a decade makes 2004

Flu Vaccines for

Overview of seasonal Influenza Vaccines and Future Directions

Health Care Personnel Vaccination in the Long Term Care Setting

Flu Vaccine Access Via Pharmacy Vaccine Network

Influenza: Questions and Answers

Influenza Prevention Update

Influenza B viruses are not divided into subtypes, but can be further broken down into different strains.

FDA Approved Recombinant Hemagglutinin Influenza Vaccine Protects Against Drift Influenza Viruses

Adult Immunization Update 2015

Influenza Vaccination for Pediatric Solid Organ Transplant Patients

Serum Institute of India Ltd. The Nasal-Spray Flu Vaccine (Live Attenuated Influenza Vaccine [LAIV])

Guideline Summary NGC-7977

Diclosures. Objectives 12/29/17

Should patients with diabetes receive an influenza vaccine yearly?

Immunization Update: What s New in 2013? Thursday, August 15, :30 a.m. 12:30 p.m.

What is Influenza? Patricia Daly MD, FRCPC Medical Health Officer and Medical Director of Communicable Disease Control

Fluzone High-Dose Vaccine and FIM12 Efficacy Trial Results

Immunization Update 2013

Ontario Public Drug Programs, Ministry of Health and Long-Term Care. For the Influenza Immunization Season

MDPH Influenza Update

Updated: 26 August 2010

What You Need to Know About the Flu

Andrew Kroger, MD, MPH National Center for Immunization and Respiratory Diseases MCH & Immunization Conference Anchorage, AK September 28, 2010

Immunization Update 2013 Across the Lifespan

9/12/2018. Influenza and Influenza Vaccines. Influenza. Influenza Virus. Highly infectious viral illness. First pandemic in 1580

Immunization Update Tamara Sheffield, MD, MPA, MPH

Vaccine Administration Considerations

Overview 10/3/2011. Vaccines for Life: 2011 Updates for ADULT SCHEDULE WHAT S NEW? Adult Immunization Schedules

Update on Adult Immunization

LECTURE OUTLINE. B. AGENT: Varicella-zoster virus. Human herpes virus 3. DNA virus.

Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011

Influenza Virus: Evolution of a Deadly Virus in our World

Influenza: Seasonal, Avian, and Otherwise

AMERICAN ACADEMY OF PEDIATRICS. Committee on Infectious Diseases

Immunization Update 2017 Peds Clinical Learning Day. Tamara Sheffield, MD, MPA, MPH

Q: If antibody to the NA and HA are protective, why do we continually get epidemics & pandemics of flu?

New Vaccine Schedules. Disclosure. Overview. Immunization Recommendations in Primary Care. Objectives Pharmacists. Objectives Pharmacy Technicians

GENERAL SAFETY ISSUES September 18, 2009

Novel H1N1 Influenza. It s the flu after all! William Muth M.D. Samaritan Health Services 9 November 2009

Seasonal Influenza Report

These slides are the property of the presenter. Do not duplicate without express written consent.

Influenza Backgrounder

New Reminder Alerts added to Online Member Health Records

H1N1 Influenza. Influenza-A Basics. Influenza Basics. April 1, History of Influenza Pandemics. April 1 September 25, 2009

Swine Flu; Symptoms, Precautions & Treatments

Revised Recommendations for the Use of Influenza Antiviral Drugs

ACIP Recommendations

Seasonal Influenza Report

General Questions and Answers on 2009 H1N1 Influenza Vaccine Safety

Immunizations: An Overview. Sutter Health May 9, 2017 John Apostolo, PharmD, MBA Heidi Rens, PharmD

Influenza Program 2018

INFLUENZA VIRUS. INFLUENZA VIRUS CDC WEBSITE

Influenza: The past, the present, the (future) pandemic

Attacking The Flu Bug The Pharmacist s s Pro-Active Role in Preventing & Treating Influenza

What is the Flu? The Flu is also called Influenza (In-flu-en-za) It is caused by an infection of the. Nose Throat And lungs

Seasonal Influenza Report

What You Need to Know About the Flu

Hot off the press, What s new for immunizations in 2017?

For the 2017/2018 Influenza Immunization Season. Patient Eligibility. Description. Ontario Public Drug Programs, Ministry of Health and Long-Term Care

Update ACIP Influenza Vaccination Recommendations for

Needle Facts: Immunization Update 2016

H1N1-A (Swine flu) and Seasonal Influenza

Influenza: Wrap- Up and Preview of the Upcoming Season. October 6, 2016 Anita Valiani, MPH

2013 Adult Immunization Update. David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle

Morbidity and Mortality Weekly Report

Influenza A(H1N1) aka Swine Flu. IAP ACVIP statement on ongoing outbreak of H1N1 in India. Situational analysis: Historical perspectives

What You Need to Know About the Flu

SANOFI PASTEUR INFLUENZA VACCINES

PUBLIC HEALTH SIGNIFICANCE SEASONAL INFLUENZA AVIAN INFLUENZA SWINE INFLUENZA

Immunization Update 2017 Adult Clinical Learning Day. Tamara Sheffield, MD, MPA, MPH

Prevention and Treatment of Seasonal Influenza. What to expect. Objectives 11/5/14

Pandemic H1N1 2009: The Public Health Perspective. Massachusetts Department of Public Health November, 2009

Seasonal Influenza. Provider Information Sheet. Infectious Disease Epidemiology Program

Transcription:

Outline Influenza Virus Population Data Vaccination Rates 2010-11 Influenza Vaccines Live Attenuated Influenza Vaccine (LAIV) High-Dose Trivalent Inactivated Vaccine (HD TIV)

Influenza Virus Influenza A virus Infect birds and some mammals including humans Antigenic drift and occasionally shift Categorized according to hemagglutinin and neuraminidase 16 different H antigens and 9 different N antigens Influenza B virus Only known to infect humans Antigenic drift, but not shift Influenza C virus Infects humans and pigs Rare compared to A & B Seasonal influenza vaccine contains 2 type-a and 1 type-b

Number of Deaths in the U.S. for Leading Causes Final Data for 2005* Heart disease: 652,091 Cancer: 559,312 Stroke (cerebrovascular diseases): 143,579 Chronic lower respiratory diseases: 130,933 Accidents (unintentional injuries): 117,809 Diabetes: 75,119 Alzheimer's disease: 71,599 Influenza/Pneumonia: 63,001 Nephritis, nephrotic syndrome, and nephrosis: 43,901 Septicemia: 34,136 *Source: Deaths: Final Data for 2005, Tables C, 7, 30 PDF Available at http://www.cdc.gov/nchs/fastats/deaths.htm

Number of Deaths in Maine for Leading Causes Final Data for 2007* Cancer: 3,112 Heart Disease: 2,852 Chronic lower respiratory diseases: 728 Stroke (cerebrovascular diseases): 664 Accidents (unintentional injuries): 584 Alzheimer's disease: 470 Diabetes: 355 Influenza/Pneumonia: 352 Nephritis, nephrotic syndrome, and nephrosis: 269 Intentional Self harm (suicide) 191 *Source: Deaths, percent of total deaths, and death rates for the 15 leading causes of death: United States and each State, 2007 PDF http://www.cdc.gov/nchs/datawh/statab/unpubd/mortabs/lcwk9_10.htm

Influenza Virus A Subtype H1N1 Most common cause of influenza in humans H1N1 strains caused roughly half of all human flu infections in 2006 Novel H1N1 outbreaks 1918 Spanish flu, 1977 Russian flu, 2009 swine flu

International Influenza Data as of August 17, 2010

Did you get your flu shots last year? 1. H1N1 flu shot only 2. Seasonal flu shot only 3. Both H1N1 and Seasonal flu shots 4. Neither flu shot

Proportion Of Adults Aged 65 And Older Who Received A Flu Shot Within The Past Year 100 90 80 70 60 50 40 30 20 10 0 1993 1997 2001 2005 2009 HM 2010 http://www.cdc.gov/flu/ Maine US

Proportion Of Adults Aged 65 And Older Who Report Ever Having Had A Pneumonia Vaccination 80 70 60 50 40 30 Maine US 20 10 0 1993 1997 2001 2005 2009 HM 2010 http://www.cdc.gov/flu/

Number of adults age 65+ who did not receive an influenza vaccination within the past year 6,000-10,000 Cumberland, York 4,000-6,000 Aroostook, Penobscot, Androscoggin 2,000-4,000 Somerset, Hancock, Lincoln, Oxford, Kennebec 500-2,000 Franklin, Knox, Piscataquis, Sagadahoc, Waldo, Washington STATE TOTAL: 53,400 CDC. Behavioral Risk Factor Surveillance System, 2000-2009.

Number of adults age 65+ who have never had a pneumonia vaccination 8,000-12,000 Cumberland, York 4,000-8,000 Kennebec, Penobscot, Androscoggin 2,000-4,000 Somerset, Hancock, Lincoln, Oxford, Knox, Washington 500-2,000 Franklin, Sagadahoc, Waldo No Data Available Piscataquis STATE TOTAL: 65,300 CDC. Behavioral Risk Factor Surveillance System, 2000-2009.

Promoting Healthier and Longer Lives Pharmacists are well positioned in rural and urban communities to boost immunization rates and lower the burden of vaccine-preventable diseases. Pharmacists can work interdependently with other stakeholders to collaboratively reach Healthy Maine 2010 goals.

2010-11 ACIP/CDC/WHO Recommendations World Health Organization: the global H1N1 pandemic is over. Routine influenza vaccination is recommended for all persons aged 6 months. The 2010--11 trivalent vaccines will contain A/California/7/2009 (H1N1)-like, A/Perth/16/2009 (H3N2)- like, and B/Brisbane/60/2008-like antigens. Persons aged 65 years can be administered any of the standard-dose TIV preparations or Fluzone High-Dose. The CDC also recommends that flu vaccine be administered to eligible recipients every year as soon as the vaccine becomes available.

Vaccine Trade Name Manufacturer Presentation Mercury (mcg/0.5 ml) Age Group No. of doses Route US Influenza Vaccines for 2010-11 Pasteur TIV Fluzone Sanofi 0.25 ml syringe 0 6 35 mos 1 or 2 IM 0.5 ml syringe 0 36 mos 1 or 2 IM 0.5 ml vial 0 36 mos 1 or 2 IM 5.0 ml MD vial 25 6 mos 1 or 2 IM TIV Fluvirin Novartis Vaccine TIV Agriflu Novartis Vaccine TIV Fluarix GlaxoSmith Kline TIV FluLaval ID Biomedical TIV Afluria CSL Biotherapy 5.0 ml MD vial 25 4 yrs 1 or 2 IM 0.5 ml syringe <1.0 4 yrs 1 or 2 IM 0.5 ml syringe 0 18 yrs 1 IM 0.5 ml syringe 0 3 yrs 1 or 2 IM 5.0 ml MD vial 25 18 yrs 1 IM 0.5 ml syringe 0 9 yrs 1 IM TIV High Dose Fluzone High Dose Sanofi Pasteur 0.5 ml syringe 0 65 yrs 1 IM LAIV FluMist Med- Immune 0.2 ml sprayer 0 2 49 yrs 1 or 2 Intranasal

TIV Administration

Live Attenuated Influenza Vaccine (LAIV) Flumist

Live Attenuated Influenza Vaccine Indication Healthy people 2 through 49 years of age Contraindications Pregnant women I pick my nose! People who have long-term health problems with: heart disease kidney or liver disease lung disease metabolic disease, such as diabetes asthma anemia, and other blood disorders Anyone with a weakened immune system.

LAIV Administration

Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children N Engl J Med 2007;356:685-96. Children 6 to 59 months of age, without a recent episode of wheezing illness or severe asthma. Randomized, double-blind study with either trivalent live attenuated influenza vaccine or trivalent inactivated vaccine. 7852 children completed the study and were monitored with culture throughout the 04-05 influenza season.

Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children N Engl J Med 2007;356:685-96.

N Engl J Med 2007;356:685-96. Medically Significant Wheezing, Serious Adverse Events, and Rates of Hospitalization According to Age Group Age Event Live Vaccine Inactivated Vaccine no. / total no. (%) 6-11 mos. Wheezing 93/684 (13.6) 71/683 (10.4) Any serious AE 44/684 (6.4) 23/683 (3.4) Hospitalization 42/684 (6.1) 18/683 (2.6) 12-59 mos. Wheezing 272/3495 (7.8) 255/3490 (7.3) Any serious AE 92/3495 (2.6) 105/3490 (3.0) Hospitalization 88/3495 (2.5) 101/3490 (2.9) 6-59 mos. Wheezing 365/4179 (8.7) 326/4173 (7.8) Any serious AE 136/4179 (3.3) 128/4173 (3.1) Hospitalization 130/4179 (3.1) 119/4173 (2.9)

High-Dose Trivalent Inactivated Vaccine (HD TIV) Fluzone HD

Methods: Multicenter, randomized, double-blind controlled study HD vaccine (which contains 60 mg of hemagglutinin per strain) SD vaccine (which contains 15 mg of hemagglutinin per strain) in adults 65 years of age and older. J Infect Dis. 2009;200(2):172-80

antibody titer level Titer Response of High-Dose Vaccine 140 120 100 700 600 500 80 60 40 20 400 300 200 100 Day 0 Day 28 0 0 A/H1N1 B J Infect Dis. 2009;200(2):172-80 A/H3N2

antibody titer level Comparison of responses to high-dose (HD) and standard-dose (SD) influenza vaccine 140 120 100 700 600 500 80 60 40 20 400 300 200 100 SD HD 0 0 A/H1N1 B J Infect Dis. 2009;200(2):172-80 A/H3N2

Percent Comparison of systemic side effects to HD and SD influenza vaccine 25 20 15 10 SD HD 5 0 Fever Headache Malaise Myalgia J Infect Dis. 2009;200(2):172-80

55 year-old woman with diabetes and asthma on glucophage 1 gm BID, Advair 250/50 1 inhalation BID, and albuterol MDI 2 puffs prn. Which flu vaccine(s) is/are indicated for her? 1. No influenza vaccine indicated 2. SD TIV 0.5 ml IM only 3. SD TIV or HD TIV 0.5 ml IM 4. SD TIV 0.5 ml IM or LAIV 0.2 ml nasal

36 year-old man whose wife is pregnant. His medical history includes seasonal allergies for which he takes cetirizine 10 mg QD. Which flu vaccine(s) is/are indicated for him? 1. No influenza vaccine indicated 2. SD TIV 0.5 ml IM only 3. SD TIV or HD TIV 0.5 ml IM 4. SD TIV 0.5 ml IM or LAIV 0.2 ml nasal

69 year-old man with a history of hypertension and a heart attack. His current medications include atenolol 100 mg QD, aspirin 81 mg QD, lisinopril 20 mg QD, NTG SL 0.4 mg prn, and Lipitor 20 mg QD. Which flu vaccine(s) is/are indicated for him? 1. No influenza vaccine indicated 2. SD TIV 0.5 ml IM only 3. SD TIV or HD TIV 0.5 ml IM 4. SD TIV 0.5 ml IM or LAIV 0.2 ml nasal

A mother of an 18 month-old boy wants a flu vaccine for him that is mercury free. The child has no allergies or medical history. Which flu vaccine do you recommend? 1. Fluzone multi-dose vial 2. Fluzone syringe 3. Fluzone HD syringe 4. Flumist nasal spray

Questions??? http://www.offthemark.com/ CDC Influenza Website http://www.cdc.gov/flu/ Flu in Maine: Maine Department of Health and Human Services http://www.maine.gov/dhhs/boh/maineflu/